OVID icon

Ovid Therapeutics

70 hedge funds and large institutions have $11.9M invested in Ovid Therapeutics in 2025 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 16 increasing their positions, 22 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

less ownership

Funds ownership:

less capital invested

Capital invested by funds: $ → $

27% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 22

39% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 28

Holders
70
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$353K
2 +$347K
3 +$165K
4
GCP
GSA Capital Partners
United Kingdom
+$99.7K
5
Goldman Sachs
Goldman Sachs
New York
+$59.2K

Top Sellers

1 -$1.6M
2 -$822K
3 -$397K
4
MAP
Madison Avenue Partners
New York
-$381K
5
State Street
State Street
Massachusetts
-$378K